Antiasthmatic drugs I: pathophysiological and clinical pharmacological aspects.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use; D000420:Albuterol / Q000627:therapeutic use; D000588:Amines / Q000627:therapeutic use; D001249:Asthma / Q000188:drug therapy* / Q000453:epidemiology / Q000473:pathology / Q000503:physiopathology; D012898:Autacoids / Q000502:physiology; D001920:Bradykinin / Q000502:physiology; D002628:Chemoreceptor Cells / Q000187:drug effects; D004205:Cromolyn Sodium / Q000627:therapeutic use; D000242:Cyclic AMP / Q000502:physiology; D006632:Histamine / Q000502:physiology; D006801:Humans; D006967:Hypersensitivity; D007700:Kinetics; D008407:Mast Cells / Q000502:physiology; D011453:Prostaglandins / Q000502:physiology; D011941:Receptors, Adrenergic / Q000187:drug effects; D012119:Respiration / Q000187:drug effects; D012701:Serotonin / Q000502:physiology; D013268:Stimulation, Chemical; D013566:Sympathomimetics / Q000627:therapeutic use; D014970:Xanthines / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D000588:Amines; D012898:Autacoids; D011453:Prostaglandins; D011941:Receptors, Adrenergic; D013566:Sympathomimetics; D014970:Xanthines; D012701:Serotonin; D006632:Histamine; D000324:Adrenocorticotropic Hormone; D000242:Cyclic AMP; D004205:Cromolyn Sodium; D000420:Albuterol; D001920:Bradykinin